Paper12697451
Langerhans-cell histiocytosis 'insight into DC biology'.
Laman JD and 4 others. Trends Immunol, 2003. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Langerhans-cell histiocytosis 'insight into DC biology'. Papers, record 12697451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12697451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histiocytosis, Langerhans-Cell | Major topic |
| Langerhans Cells | Major topic |
| CD40 Ligand | |
| Cell Cycle | |
| Cell Differentiation | |
| Cell Movement | |
| Humans | |
| Ki-67 Antigen | |
| Phenotype | |
| Receptors, CCR6 | |
| Receptors, CCR7 | |
| Receptors, Chemokine | |
| T-Lymphocytes |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 12909451 | Langerhans-cell histiocytosis: neoplasia or unbridled inflammation? | https://conductscience.org/library/papers/12909451 |
Source PubMed
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40501643 | An intermediate activation state primes Langerhans cell migration from the epidermis. | bioRxiv | 2025 | https://conductscience.org/library/papers/40501643 | PubMed |
| 40485762 | Cystic bone Lesions: Diagnostic pitfalls and therapeutic considerations. | J Clin Orthop Trauma | 2025 | https://conductscience.org/library/papers/40485762 | PubMed |
| 40248743 | High CCR6 expression increases the risk of pediatric Langerhans cell histiocytosis. | Blood Sci | 2025 | https://conductscience.org/library/papers/40248743 | PubMed |
| 38612250 | Pulmonary Langerhans Cell Histiocytosis in an African Lion: A Rare Case Report. | Animals (Basel) | 2024 | https://conductscience.org/library/papers/38612250 | PubMed |
| 38217750 | The value of 18F-FDG PET/CT in Langerhans cell histiocytosis. | Ann Nucl Med | 2024 | https://conductscience.org/library/papers/38217750 | PubMed |
| 37389594 | Serum levels of soluble interleukin 2 receptor (sIL-2R), tumor necrosis factor-alpha (TNF-α), and immunoglobulin M are correlated with the disease extent in childhood Langerhans cell histiocytosis. | J Cancer Res Clin Oncol | 2023 | https://conductscience.org/library/papers/37389594 | PubMed |
| 36788737 | Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis. | Cancer Sci | 2023 | https://conductscience.org/library/papers/36788737 | PubMed |
| 36714021 | Detection of Immune Microenvironment Changes and Immune-Related Regulators in Langerhans Cell Histiocytosis Bone Metastasis. | Biomed Res Int | 2023 | https://conductscience.org/library/papers/36714021 | PubMed |
| 35648675 | BRAF-V600E utilizes posttranscriptional mechanisms to amplify LPS-induced TNFα production in dendritic cells in a mouse model of Langerhans cell histiocytosis. | J Leukoc Biol | 2022 | https://conductscience.org/library/papers/35648675 | PubMed |
| 34727265 | Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers. | Int Ophthalmol | 2022 | https://conductscience.org/library/papers/34727265 | PubMed |
| 34559487 | Langerhans cell histiocytosis: Case report and literature review | Biomedica | 2021 | https://conductscience.org/library/papers/34559487 | PubMed |
| 34352902 | Rare Diseases of the Nose, the Paranasal Sinuses, and the Anterior Skull Base. | Laryngorhinootologie | 2021 | https://conductscience.org/library/papers/34352902 | PubMed |
| 34194804 | A case of langerhans cell histiocytosis of the mandible that spontaneously regressed after biopsy in a child. | Clin Case Rep | 2021 | https://conductscience.org/library/papers/34194804 | PubMed |
| 34146441 | Langerhans cell histiocytosis: A malignant myeloid neoplasm or disorder of immune regulation? | Acta Paediatr | 2021 | https://conductscience.org/library/papers/34146441 | PubMed |
| 32601132 | MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. | Cold Spring Harb Perspect Med | 2021 | https://conductscience.org/library/papers/32601132 | PubMed |
| 31893135 | Langerhans cell histiocytosis of the orbit and frontal sinus of the adult woman: A first case report in Poland. | Surg Neurol Int | 2019 | https://conductscience.org/library/papers/31893135 | PubMed |
| 31293989 | Eruptive Junctional Nevi Appearing During Langerhans Cell Histiocytosis Treatment. | Eur J Case Rep Intern Med | 2019 | https://conductscience.org/library/papers/31293989 | PubMed |
| 30157397 | Langerhans-Cell Histiocytosis. | N Engl J Med | 2018 | https://conductscience.org/library/papers/30157397 | PubMed |
| 29618940 | Langerhans cell histiocytosis with hemorrhagic uveitis and exudative retinal detachment. | Int Med Case Rep J | 2018 | https://conductscience.org/library/papers/29618940 | PubMed |
| 29563927 | Herpes Simplex Virus and Langerhans Cell Histiocytosis. | Iran J Pathol | 2017 | https://conductscience.org/library/papers/29563927 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12697451
GET https://conductscience.org/api/papers/v1/12697451/cited_by?page=2